Rodríguez-Vélez, R. et al. 2010. Exposure to Non-Therapeutic INR in a High Risk Cardiovascular Patient: Potential Hazard Reduction with Genotype-guided Warfarin (Coumadin®) Dosing. Puerto Rico Health Sciences Journal. 29, 4 (Nov. 2010).